Adam Raymakers
@adamr_phd
Post-doc: @PORTAL_research @harvardmed
Science Alliance: @protectwintersc
Formerly: @BCCancer, @SFU_FHS, @HEPAC_Galway, @UBC_CORE
Cape Bretoner
#FirstGen
ID: 595778022
https://www.linkedin.com/in/araymakers/ 31-05-2012 18:07:15
6,6K Tweet
3,3K Takipçi
4,4K Takip Edilen
Presenting some work on QALY-based cost-effectiveness analyses at #SMDM24 that shows some arguments against the use of QALYs have little empirical justification. Program On Regulation, Therapeutics, And Law
